# Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye

> **NCT05062564** · NA · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria Careggi** · enrollment: 46 (actual)

## Conditions studied

- Meibomian Gland Dysfunction
- Cataract
- Surgery--Complications
- Dry Eye
- Blepharitis

## Interventions

- **DEVICE:** LipiFlow Thermal pulsation system
- **PROCEDURE:** Eyelid warm compresses plus massages

## Key facts

- **NCT ID:** NCT05062564
- **Lead sponsor:** Azienda Ospedaliero-Universitaria Careggi
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-07
- **Primary completion:** 2022-01-17
- **Final completion:** 2022-01-17
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2022-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05062564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05062564, "Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05062564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*